Chemours

CC · NYSE

$12.97+$0.35 (+2.77%)TodayMarket closed · Oct 20, 7:45 PM ET

Prev close $12.62

CC analyst rating

HoldConsensus of 9 analysts over the last 12 months. 33% rate it a buy.

Strong buy0
Buy3
Hold6
Underperform0
Sell0

12-month price target · 14 analysts

Average $19.31 (+48.8% upside)

Low: $17.17
Now: $12.97
High: $25.20

Upgrades and downgrades

The latest rating actions, newest first

CC analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Truist Securities	Oct 20, 2026	Maintains	Buy	$24.00 → $20.00	43%
Mizuho	Oct 14, 2026	Downgrade	Outperform → Neutral	$18.00 → $15.00	62%
Barclays	Oct 13, 2026	Initiates	Equal-Weight	$16.00	50%
UBS	Oct 5, 2026	Maintains	Neutral	$18.00 → $16.00	49%
Mizuho	Sep 30, 2026	Maintains	Outperform	$20.00 → $18.00	62%
JP Morgan	Aug 13, 2026	Maintains	Neutral	$22.00 → $15.00	57%
BMO Capital	Aug 13, 2026	Maintains	Outperform	$26.00 → $18.00	50%
UBS	Aug 10, 2026	Downgrade	Buy → Neutral	$29.00 → $18.00	49%
RBC Capital	Aug 6, 2026	Maintains	Outperform	$26.00 → $22.00	46%
Truist Securities	Aug 6, 2026	Maintains	Buy	$30.00 → $24.00	43%

The case for and against

Updated Oct 22, 2025

Bull case

Chemours Co is positioned for a positive financial outlook, primarily due to its ability to raise prices for Flex portal and distribution customers, which indicates strong pricing power in the market. Furthermore, the company anticipates improved TiO2 margins by 2025, despite facing near-term challenges from higher raw material costs and sluggish demand in Europe and Asia. Additionally, Chemours's ongoing "Pathway to Thrive" plan is projected to generate over $250 million in incremental run-rate cost savings through 2027, with a significant portion expected to be realized by the end of 2025.

Bear case

Chemours faces significant challenges that contribute to a negative outlook on its stock, primarily stemming from a slowdown in demand for hydrofluorocarbons (HFCs) and hydrofluoroolefins (HFOs) due to regulatory changes, alongside heightened competition in HFO technology. Additionally, new capacity announcements in the TiO2 segment threaten to exacerbate existing weaknesses in pricing and end-market demand, particularly in the housing and automotive sectors. The company is also impacted by weakening global macroeconomic conditions, which further dampen its revenue prospects, especially as it relies heavily on its Titanium Technologies segment for income generation.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.